AU529982B2 - N-substituted aziridine -2-carboxylic acid derivatives - Google Patents

N-substituted aziridine -2-carboxylic acid derivatives

Info

Publication number
AU529982B2
AU529982B2 AU55649/80A AU5564980A AU529982B2 AU 529982 B2 AU529982 B2 AU 529982B2 AU 55649/80 A AU55649/80 A AU 55649/80A AU 5564980 A AU5564980 A AU 5564980A AU 529982 B2 AU529982 B2 AU 529982B2
Authority
AU
Australia
Prior art keywords
radical
cyano
general formula
aziridine
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU55649/80A
Other languages
English (en)
Other versions
AU5564980A (en
Inventor
Uwe Bicker
Dietmar Boerner
Elmar Bosies
Wolfgang Kampe
Max Thiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU5564980A publication Critical patent/AU5564980A/en
Application granted granted Critical
Publication of AU529982B2 publication Critical patent/AU529982B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/22—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU55649/80A 1979-02-21 1980-02-18 N-substituted aziridine -2-carboxylic acid derivatives Ceased AU529982B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE29066033 1979-02-21
DE19792906603 DE2906603A1 (de) 1979-02-21 1979-02-21 N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
AU5564980A AU5564980A (en) 1980-08-28
AU529982B2 true AU529982B2 (en) 1983-06-30

Family

ID=6063481

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55649/80A Ceased AU529982B2 (en) 1979-02-21 1980-02-18 N-substituted aziridine -2-carboxylic acid derivatives

Country Status (19)

Country Link
US (2) US4397848A (cg-RX-API-DMAC7.html)
EP (1) EP0014976B1 (cg-RX-API-DMAC7.html)
JP (1) JPS55113760A (cg-RX-API-DMAC7.html)
AR (1) AR223863A1 (cg-RX-API-DMAC7.html)
AT (1) ATE818T1 (cg-RX-API-DMAC7.html)
AU (1) AU529982B2 (cg-RX-API-DMAC7.html)
CA (1) CA1148962A (cg-RX-API-DMAC7.html)
CS (1) CS208798B2 (cg-RX-API-DMAC7.html)
DD (1) DD148772A5 (cg-RX-API-DMAC7.html)
DE (2) DE2906603A1 (cg-RX-API-DMAC7.html)
ES (1) ES488656A1 (cg-RX-API-DMAC7.html)
FI (1) FI70702C (cg-RX-API-DMAC7.html)
HU (1) HU182801B (cg-RX-API-DMAC7.html)
IE (1) IE49267B1 (cg-RX-API-DMAC7.html)
IL (1) IL59425A (cg-RX-API-DMAC7.html)
PL (1) PL129707B1 (cg-RX-API-DMAC7.html)
PT (1) PT70847A (cg-RX-API-DMAC7.html)
SU (1) SU1181541A3 (cg-RX-API-DMAC7.html)
ZA (1) ZA80902B (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925835A (en) * 1986-05-01 1990-05-15 Sloan-Kettering Institute For Cancer Research Aziridinyl putrescine containing compositions and their uses in treating prostate cancer
JPH07301287A (ja) * 1995-03-23 1995-11-14 Sumitomo Heavy Ind Ltd 制御装置に用いられる内接噛合遊星歯車機構
US6297230B1 (en) 1997-06-27 2001-10-02 Amplimed, Inc. Cyanoaziridines for treating cancer
WO2002041871A2 (en) * 2000-11-21 2002-05-30 Board Of Regents, The University Of Texas System Composition comprising an imexon or derivatives thereof and lipids
US20030129222A1 (en) * 2000-11-21 2003-07-10 Gabriel Lopez-Berestein Liposomal imexon
ATE374602T1 (de) * 2001-12-21 2007-10-15 Supernus Pharmaceuticals Inc Orale kapselformulierung mit verbesserter physikalischer stabilität
US20040005339A1 (en) * 2002-06-28 2004-01-08 Shojaei Amir H. Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
RS20050532A (sr) 2003-01-14 2007-12-31 Arena Pharmaceuticals Inc., Derivati 1,2,3-trisupstituisanog arila i heteroarila kao modulatori metabolizma za profilaksu i tretman poremećaja povezanih sa njim, kao što su dijebetes i hiperglikemija
DE602004017703D1 (de) * 2003-02-24 2008-12-24 Arena Pharm Inc Phenyl- und pyridylpiperidinderivate als modulatoren des glucose-metabolismus
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
EA011671B1 (ru) * 2004-06-04 2009-04-28 Арена Фармасьютикалз, Инк. Замещенные производные арила и гетероарила в качестве модуляторов метаболизма и для профилактики и лечения связанных с ним расстройств
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) * 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
BRPI0616245A2 (pt) * 2005-09-16 2011-06-14 Arena Pharm Inc modulador de metabolismo, seus usos, composiÇço farmaceutica compreendendo o mesmo, bem como mÉtodo para produÇço da referida composiÇço
TW200811147A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811140A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
EP2528894A1 (en) 2010-01-27 2012-12-05 Arena Pharmaceuticals, Inc. Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
CN103221410B (zh) 2010-09-22 2017-09-15 艾尼纳制药公司 Gpr119受体调节剂和对与其相关的障碍的治疗
CA3002540C (en) 2015-01-06 2023-11-07 Arena Pharmaceuticals, Inc. Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor
JP6838744B2 (ja) 2015-06-22 2021-03-03 アリーナ ファーマシューティカルズ， インコーポレイテッド Ｓ１Ｐ１レセプター関連障害における使用のための（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸（化合物１）の結晶性Ｌ−アルギニン塩
CN110520124A (zh) 2017-02-16 2019-11-29 艾尼纳制药公司 用于治疗原发性胆汁性胆管炎的化合物和方法
JP7397011B2 (ja) 2018-06-06 2023-12-12 アリーナ ファーマシューティカルズ， インコーポレイテッド Ｓ１ｐ１受容体に関連する状態を治療する方法
CN113816887A (zh) * 2021-08-31 2021-12-21 华中科技大学 一种氮杂环丙烷类化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2644820A1 (de) * 1976-10-05 1978-04-06 Boehringer Mannheim Gmbh Cancerostatisch und immunstimulierend wirkende 1-(n-acyl-carbamoyl)-2-cyanaziridine sowie verfahren zur herstellung derselben
DE2731264A1 (de) 1977-07-11 1979-02-01 Boehringer Mannheim Gmbh Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen

Also Published As

Publication number Publication date
SU1181541A3 (ru) 1985-09-23
ATE818T1 (de) 1982-04-15
EP0014976B1 (de) 1982-04-07
AU5564980A (en) 1980-08-28
JPH0150700B2 (cg-RX-API-DMAC7.html) 1989-10-31
IE800327L (en) 1980-08-21
US4517183A (en) 1985-05-14
PL129707B1 (en) 1984-06-30
CS208798B2 (en) 1981-09-15
EP0014976A1 (de) 1980-09-03
US4397848A (en) 1983-08-09
AR223863A1 (es) 1981-09-30
DD148772A5 (de) 1981-06-10
IE49267B1 (en) 1985-09-04
PT70847A (de) 1980-03-01
FI800510A7 (fi) 1980-08-22
IL59425A0 (en) 1980-05-30
JPS55113760A (en) 1980-09-02
ES488656A1 (es) 1980-09-16
FI70702C (fi) 1986-10-06
ZA80902B (en) 1981-03-25
IL59425A (en) 1984-05-31
HU182801B (en) 1984-03-28
CA1148962A (en) 1983-06-28
PL222088A1 (cg-RX-API-DMAC7.html) 1980-12-01
FI70702B (fi) 1986-06-26
DE3060268D1 (en) 1982-05-19
DE2906603A1 (de) 1980-09-04

Similar Documents

Publication Publication Date Title
AU540477B2 (en) Azolyloxy-carboxylic acid amides
AU544515B2 (en) Heterocyclic amino acid derivatives
AU6176280A (en) Substituted n-benzoylanthranilic acid derivatives
PT71744A (en) Substituted beta-carbolin-3-carboxylic acid derivatives
AU5564980A (en) N-substituted aziridine -2-carboxylic acid derivatives
AU540102B2 (en) Tetrazolyloxycarboxylic acid amides
AU551079B2 (en) Glycidyliso cyanuric acid derivatives
AU531466B2 (en) Acid amides
GB2117774B (en) Oximinoacetic acid derivatives
AU541989B2 (en) Dialkoxy-phosphonyl-n-alkyl-formic acid amides
GB2106896B (en) N-substituted aziridine-2-carboxylic acid derivatives
AU5607380A (en) Azole - substituted atropic acid derivatives
AU518251B2 (en) L-halomethyl amino acid derivatives
AU530997B2 (en) N-substituted aziridine-2-carboxylic acid derivatives
AU533620B2 (en) Pyrrolidinyl-sulfamoylbenzoic acid derivatives
AU537900B2 (en) Dihydronicotinic acid derivatives
AU5863380A (en) Acid derivatives
GB2053912B (en) Acylaminobenzoic acid derivatives
AU532433B2 (en) Halophthalamic acid amide
AU5780580A (en) Amine derivatives
AU4820479A (en) N-substituted triorganostannyl-hydrocarbylcarboxylic acid
AU6274380A (en) Monic acid derivatives
AU4599979A (en) Diisatoic acid or triisatoic acid derivatives
GB2050377B (en) Pyrazinoquinoxaline derivatives
ZA803734B (en) Acylaminobenzoic acid derivatives